Interestingly, we found gradual and significant decline of CD4+CD25+Foxp3+Treg cells during anti-TB therapy and at 12 month their percentages came down to the levels comparable with HCs (Fig. 4A,Fig. S2). This evidence concerns the gene FOXP3 and tuberculosis.